Background
==========

Drug-induced noncardiogenic lung edema is one of the pulmonary manifestations of the life-threatening side effects resulting from an overdose of medicines. All four subgroups of calcium channel blockers (CCB) have been reported to lead to both cardiogenic and noncardiogenic pulmonary edema \[[@B1]-[@B8]\]. CCB-induced noncardiogenic edema appears to be due to diffuse damage and increased permeability of the alveolocapillary membrane, which results in accumulation of excess fluid in alveolar air spaces \[[@B9]\]. To keep the alveolar space free from flooding, accumulated cytosolic salts are extruded \[[@B10]-[@B12]\]. The major determinant pathway for this process is apically located epithelial Na^+^channels (ENaC). Increasing amounts of etiological evidence suggests that genetic and pathologic ENaC deficiency gives rise to the genesis of flooding airspaces \[[@B13],[@B14]\]. For example, α ENaC knockout leads to the death of newborn mice due to their inability to resolve amniotic fluid in their lungs \[[@B15]\]. In adult lungs, high attitude pulmonary edema and pathogen-challenged edematous lung injuries have been linked to a reduction of both ENaC expression and activity levels \[[@B16],[@B17]\].

Basolateral K^+^channels in epithelia play a major role in maintaining the electrochemical gradient necessary for Na^+^and Cl^-^transepithelial transport, and in restoring the resting membrane potential. The potential physiological importance of voltage-gated K^+^channels (K~V~), calcium-activated K^+^channels (K~Ca~), and ATP-sensitive K^+^channels (K~ATP~) in transepithelial ion transport has been implicated \[[@B18]-[@B22]\]. K~V~channels constitute a large family (*i.e*., K~V~LQT1-K~V~7.1, KNCQ, and KCNQ channels). So far, KCNQ 3 and 5 but not 1 have been identified in H441 cells by a very recent publication \[[@B23]\]. K~Ca~channels, until recently known as K ~Ca3.1~and BK~Ca~, are functionally detected in ENaC-expressing primary airway and ATII cells \[[@B24]-[@B26]\]. These commonly basolaterally located K ~Ca3.1~channels are blocked by clotrimazole and are activated by 1-ethyl-2-benzimidazolinone (1-EBIO). K~ATP~channels, which can be inhibited by glibenclamide and activated by minoxidil, have been identified in both fetal and adult alveolar cells \[[@B21],[@B27]\]. These three types of K^+^channels have been confirmed to functionally modify the ionic and fluid transepithelial transport in cystic fibrosis airway epithelial cells \[[@B22]\] and may have an important role in lung fluid clearance \[[@B21],[@B28]\]. These crucial K^+^channels together with basolaterally located Na^+^/K^+^-ATPase recycle K^+^ions across interstitial membrane of alveolar cells. The regulation of transepithelial Na^+^transport by the K^+^channel blockers in normal primary alveolar type II cells has recently been reported \[[@B21],[@B25]\]. The underlying mechanisms for the coupling of Na^+^and K^+^transport are unknown. More importantly, K^+^channel openers facilitated alveolar fluid clearance in resected human lungs \[[@B29]\] and transepithelial ion transport in human airway \[[@B30]\]. However, whether K^+^channel openers are able to restore the CCB-inhibited transepithelial salt and fluid clearance in edematous lungs remains to be elucidated.

Verapamil has been broadly used clinically for combating hypertension, ischemic heart diseases, supraventricular tachyarrhythmias, and tycolysis. In this study, we investigated the effects of verapamil on ENaC activity in confluent H441 monolayers-a human bronchoalveolar epithelial cell line, in *Xenopus*oocytes heterologously expressing human αβγ ENaC, and in murine lungs. Our results showed that K^+^channel openers recovered verapamil-inhibited vectorial Na^+^transport in H441 cells. Moreover, verapamil-reduced alveolar fluid resolution can be restored by these K^+^channel openers in murine lungs.

Methods
=======

Cell culture
------------

NCI-H441 (H441) cells were obtained from the American Type Culture Collection (ATCC). H441 cells were grown in RPMI medium (ATCC) containing 10% fetal bovine serum (FBS), 2 mM L-glutamine, 10 mM HEPES, 1 mM sodium pyruvate, 4.5 g/L glucose, 1.5 g/L sodium bicarbonate and antibiotics (100 U/ml penicillin and 100 μg/ml streptomycin). Dexamethasone (250 nM, Sigma) was supplemented to stimulate ENaC expression. Cells were seeded on permeable support filters (Costar) at a supraconfluent density (\~5 × 10^6^cells/cm^2^), and incubated in a humidified atmosphere of 5% CO~2~-95% O~2~at 37°C. Cells reached confluency in the Costar Snapwell culture cups 24 hrs after plating. At this point media and non-adherent cells in the apical compartment were removed to adapt the cells to air-liquid interface culture. Culture media in the basolateral compartment was replaced every other day; whereas the apical surface was rinsed with PBS. An epithelial tissue voltohmmeter (World Precision Instruments) was used to monitor the transepithelial resistance. Highly polarized tight monolayers with resistance \>800 Ω·cm^2^were selected for Ussing chamber assays.

*In vivo*alveolar fluid clearance
---------------------------------

Animals were kept under pathogen-free conditions, and all procedures performed were approved by the Institutional Animal Care and Use Committee of the University of Texas Health Science Center at Tyler. Alveolar fluid clearance was examined *in vivo*as previously described by us and other groups \[[@B31]-[@B34]\]. Briefly, 8-10 week old, weighting 20-30 g, pathogen-free, male C57/BL/6 mice were used (National Cancer Institute). An isosmotic instillate containing 5% bovine serum albumin (BSA) was prepared with 0.9% NaCl. Anesthetized mice were ventilated with 100% O~2~via a volume-controlled ventilator (model 683, Harvard Apparatus) for a 30-minute period. 5% BSA (0.3 ml), with or without verapamil (100 μM) and amiloride (1 mM) was instilled intratracheally. The instilled alveolar fluid was aspirated by applying gentle suction to the tracheal catheter with a 1-ml syringe. The BSA content of the alveolar fluid was measured with a 96-well microplate reader. Alveolar fluid clearance (AFC) was calculated as follows: AFC = (Vi - Vf)/Vi\*100, where Vi and Vf denote the volume of the instilled and recovered alveolar fluid, respectively. Vf was obtained as Vf = (Vi \* Pi )/Pf, where Pi and Pf represent protein concentration of instilled and collected fluid.

Ussing chamber assays
---------------------

Measurements of short-circuit current (Isc) in H441 monolayers were performed as described previously \[[@B35]\]. Briefly, H441 monolayers were mounted in vertical Ussing chambers (Physiologic Instruments) and bathed on both sides with solutions containing (in mM) 120 NaCl, 25 NaHCO~3~, 3.3 KH~2~PO~4~, 0.83 K~2~HPO~4~, 1.2 CaCl~2~, 1.2 MgCl~2~, 10 HEPES, 10 mannitol (apical compartment) and 10 glucose (basolateral compartment). Each solution was iso-osmolalic (approximately 300 mmol/Kg), as measured by a freezing depression osmometer (Wescor). The transepithelial Isc levels were measured with 3 M KCl, 4% agar bridges placed 3 mm on either side of the membrane, which were connected on either side to Ag-AgCl electrodes. The filters were bathed on both sides with the above salt solution as designed, bubbled continuously with a 95% O~2~-5% CO~2~gas mixture (pH 7.4). The temperature of the bath solution (37°C) was maintained using a water bath. The transmonolayer potential was short-circuited to 0 mV, and Isc level was measured with an epithelial voltage clamp (VCC-MC8, Physiologic Instruments). A 10-mV pulse of 1s duration was imposed every 10s to monitor Rt. Data were collected using the Acquire and Analyse program (version 2.3; Physiologic Instruments). When Isc level reached plateau, drugs were pipetted to the either apical or basolateral compartment.

To determine whether verapamil decreases the amiloride-sensitive Isc level across the apical membrane, 100 μM amphotericin B, a pore-forming antibiotic (Sigma), was added to the basolateral side of Ussing chamber to permeabilize the basolateral membrane \[[@B36]\]. A 145:25 mM Na^+^ionic gradient (apical to basolateral compartment) was established by replacing 120 mM Na^+^ions with equal molar N-methyl-D-glucamine, an impermeant cation in the basolateral bath solution. Basolateral permeabilization equilibrates intracellular Na^+^concentration to 25 mM in the basolateral bath. To exclude any potentially residual Na^+^/K^+^-ATPase activity, 1 mM ouabain was added to the interstitial compartment. Under these experimental conditions, amiloride-sensitive Isc level reflects passive electrogenic Na^+^movement through ENaC down the Na^+^concentration gradient \[[@B37],[@B38]\]. When Isc level had attained its stable level, verapamil was applied to the apical side and amiloride-sensitive current component was determined by adding 100 μM amiloride.

To examine the ouabain-inhibitable Isc level across the basolateral membrane, the apical membrane was permeabilized with 10 μM amphotericin B. Apical permeabilization loads the cytosol with Na^+^ions thereby eliciting the maximal active Na^+^transport by the Na^+^/K^+^-ATPase \[[@B39]\]. To eliminate any remaining ENaC activity, 100 μM amiloride was included in the apical bath. Under these experimental conditions, ouabain-inhibitable basolateral Isc shall associate with Na^+^/K^+^-ATPase, tightly coupling with K^+^channels. When the Isc level was stable, verapamil and K^+^channel modulators were applied. To determine Na^+^/K^+^-ATPase activity, 1 mM ouabain was added to the basolateral compartment at the end of recording.

Oocyte preparation and voltage clamp analysis
---------------------------------------------

Oocytes were surgically removed from appropriately anesthetized adult female *Xenopus laevis*(Xenopus Express) and cRNAs for human α, β, and γ ENaC were prepared as described previously \[[@B40]\]. Briefly, the ovarian tissue was removed from frogs under anesthesia by ethyl 3-aminobenzoate methanesulfonate salt (Sigma) through a small incision in the lower abdomen. Follicle cells were removed and digested in OR-2 Ca^2+^-free medium (in mM: 82.5 NaCl, 2.5 KCl, 1.0 MgCl~2~, 1.0 Na~2~HPO~4~, and 10.0 HEPES, pH 7.5) with the addition of 2 mg/ml collagenase (Roche Indianapolis). Defolliculated oocytes were cytosolically injected with ENaC cRNAs (25 ng) per oocyte in 50 nl of RNase free water and incubated in half-strength L-15 medium at 18°C for 48 h. Oocytes were impaled with two electrodes filled with 3 M KCl, having resistances of 0.5-2 MΩ. A TEV-200 voltage clamp amplifier (Dagan) was used to clamp oocytes with concomitant recording of currents. The continuously perfused bathing solution was ND96 medium (in mM: 96.0 NaCl, 1.0 MgCl~2~, 1.8 CaCl~2~, 2.5 KCl, and 5.0 HEPES, pH 7.5). To prepare a Ca^2+^-free bath solution, CaCl~2~was omitted and 5 mM EGTA was added. To chelate intracellular Ca^2+^ions, 10 μM BAPTA_AM was added to the Ca^2+^-free bath solution. Experiments were controlled by pCLAMP 10.1 software (Molecular Devices), and currents at -40, -100, and +80 mV were continuously monitored with an interval of 10 s. Data were sampled at the rate of 1,000 Hz and filtered at 500 Hz.

Fluo 4 AM measurements
----------------------

Intracellular Ca^2+^signal elicited by ionomycin in epithelial cells was measured as described previously \[[@B41]-[@B44]\]. H441 cells were grown on chambered coverglass for 48 h. Culture medium was aspirated and cells were loaded with cell permeable Fluo 4 AM dye (4 μM, Invitrogen, CA) for 1 h. The Fluo 4 AM loaded cells were then incubated with verapamil or culture medium for 10 min. The cells were placed on the specimen stage of an inverted microscope (AxioObserver Z1, Carl Zeiss) equipped with a LSM 510 Meta confocal system (Carl Zeiss, Germany). The argon ion 488 nm laser line was used to excite Fluo 4 AM fluorochrome and the serial live cell images for the emission signal of Fluo 4 AM were captured for a period of 6 min 40 s at an interval of 4 s using a 20 ×/0.8 Plan-apochromate objective lens. Subsequent to a 2 min image acquisition, 15 nM ionomycin was added into the chamber to evoke an increment in cytosolic Ca^2+^signal. In all cases, a confluent field of cells was chosen for imaging. The relative Ca^2+^signal was measured as the ratio of fluorescent intensity (F/F0) using ZEN 2007 Zeiss imaging software and plotted as a function of recording time.

Statistics
----------

Electrophysiological data from Ussing chamber and voltage-clamp studies were primarily analyzed with the Acquire and Analyze 2.3 (Physiologic Instruments) and Clampfit 10.1 (Molecular Devices), respectively. The measurements were then imported into OriginPro 8.0 (OriginLab) for statistical computation and graphic plot. The IC~50~and EC~50~values of verapamil and K^+^channel openers were calculated by fitting the dose-response curves with the Hill equation.

All results are presented as mean ± S.E.M. The unsorted data were examined for the normal distribution using either the Kolmogorov-Smirnov normality test with specified parameters previously published or Lilliefors test. Those without significantly drawn from the normally distributed population were selected for t-test and ANOVA analyses. For the comparison of mean values of repeated measures of short-circuit and whole-cell activities, paired two-tailed Student t-test was used. For unpaired electrophysiological data, one-way ANOVA analysis combined with a post hoc Tukey-Kramer test was used. For analyses of *in vivo*alveolar fluid clearance, mean values between control and CCB challenged groups were compared by the unpaired two-sample Student t-test for both equal variance assumed or not. The mean and SE values of amiloride-sensitive AFC fraction were computed using the following equations:

and

where *M~t~*and *M~a~*are mean values of total and amiloride-resistant fractions; *t~c~*is the t~.95~value of a freedom of (*n~t~+n~a~-2*) in the t-table; *SE~t~*and *SE~a~*are SE values of total and amiloride-resistant AFC. *M, SE*, and *n*stand for mean, standard error, and number of mice, respectively. For nonparametric data (*i.e*., Ca^2+^signal), the Mann-Whitney U-test was used. The power of sample size was simultaneously evaluated to assure the actual power value \> 0.95. *P*\< 0.05 was considered statistically significant.

Results
=======

Verapamil reduces murine *in vivo*fluid resolution
--------------------------------------------------

To examine the potential deleterious effects of calcium channel blockers (CCB) on fluid resolution in distal lung air spaces, we measured *in vivo*alveolar fluid clearance (AFC) in anesthetized C57/B6 mice. As plasma verapamil predominately affects cardiovascular function, which may lead to both cardiogenic and noncardiogenic pulmonary edema as reported clinically \[[@B1]-[@B8]\], we intratracheally delivered verapamil into lung to avoid any dysfunction beyond air spaces. As shown in Fig. [1A](#F1){ref-type="fig"}, the normal AFC rate was 23.6 ± 1.3% (n = 15). Intratracheal instillation of verapamil (100 μM) markedly reduced the re-absorption of the 5% BSA instillate (11.4 ± 1.2%, *P*\< 0.05, n = 12), which was almost identical to that in the presence of amiloride (1 mM, 12.1 ± 0.8%, n = 4, *P*\< 0.05 *vs*Control). In the presence of both amiloride and verapamil, fluid resolution was 10.6 ± 0.9% (*P*\< 0.01 *vs*Control, n = 4), suggesting that verapamil almost completely inhibited amiloride-sensitive fraction of AFC (Fig. [1B](#F1){ref-type="fig"}). These *in vivo*data clearly demonstrate that CCB impairs transalveolar fluid clearance, which in turn results in fluid accumulation in lung sacs.

![**Recovery of verapamil-reduced alveolar fluid clearance (AFC) by K^+^channel openers *in vivo***. **(A)**Verapamil intratracheal application reduces alveolar fluid clearance. Verapamil (100 μM) was intratracheally delivered to mouse lung. Average AFC values in the absence of drugs (Control), in the presence of amiloride (Amiloride), verapamil (Verapamil), and both (Amiloride+Verapamil). Unpaired two-sample two-tailed Student t-test. \**P*\< 0.05 and \*\**P*\< 0.01 when compared with Control. n = 4-15. **(B)**Amiloride-sensitive (AS) AFC. The mean and SE values were computed as described in Methods. Unpaired two-sample two-tailed Student t-test. \*\**P*\< 0.01. n = 12-15. **(C)**Effects of K^+^channel openers on basal AFC. Unpaired two-sample two-tailed Student t-test. n = 5-15. **(D)**K^+^channel openers restore verapamil-reduced AFC. AFC values were measured for Verapamil (100 μM) alone, + Pyrithione-Na (1 mM), + 1-EBIO (1 mM), and +Minoxidil (0.6 mM). The dashed line indicates the Control level. Unpaired two-sample two-tailed Student t-test. \**P*\< 0.05 *vs*Verapamil alone. n = 4-12.](1465-9921-11-65-1){#F1}

K^+^channel openers profoundly restore verapamil-inhibited alveolar fluid clearance
-----------------------------------------------------------------------------------

K^+^channel openers activated transepithelial ion transport in alveolar monolayers *in vitro*under physiological conditions \[[@B25]\]. It prompted us to hypothesize that K^+^channel openers may be capable of recovering the verapamil-inhibited fluid resolution *in vivo*. To address this promising pharmaceutical issue, three types of K^+^channel openers, namely, pyrithione-Na (1 mM for K~V~), 1-EBIO (1 mM for K ~Ca3.1~), and minoxidil (0.6 mM for K~ATP~) were intratracheally delivered in the presence (Fig. [1D](#F1){ref-type="fig"}) and absence of verapamil (Fig. [1C](#F1){ref-type="fig"}). The K^+^openers slightly but not significantly altered AFC (Fig. [1C](#F1){ref-type="fig"}). In sharp contrast, depressed AFC (10.4 ± 1.3%) in the presence of verapamil was pronouncedly relieved by 1-EBIO (17.6 ± 2.5%, n = 4, *P*\< 0.05) and minoxidil (17.3 ± 2.3%, n = 4, *P*\< 0.05). These data suggest that augmentation of K^+^efflux from lung epithelial cytosol facilitates salt/fluid re-absorption in verapamil-injured edematous lungs.

Calcium antagonists abrogate transepithelial short-circuit current (Isc) in intact H441 monolayers
--------------------------------------------------------------------------------------------------

Human bronchoalveolar epithelium-derived Clara cells (H441) have been used extensively to study lung epithelial Na^+^channels, in which ENaC properties are similar to those in primary alveolar type II cells \[[@B45]-[@B48]\]. To examine the effects of verapamil on the electrogenic transepithelial Na^+^transport in lung epithelial cells, confluent H441 monolayers were mounted in an 8-chamber Ussing chamber system. Verapamil inhibited Isc levels when applied to the luminal side of H441 monolayers in a dose-dependent manner (Fig. [2A](#F2){ref-type="fig"}). The IC~50~value was 294.2 μM calculated by fitting the dose-response curve with the Hill equation (Fig. [2B](#F2){ref-type="fig"}). Nevertheless, verapamil did not affect the Isc levels in amiloride-exposed monolayers (Fig. [2C](#F2){ref-type="fig"} &[2D](#F2){ref-type="fig"}, before 2.1 ± 0.6 μA/cm^2^and after verapamil 2.0 ± 0.2 μA/cm^2^, *P*\>0.05, n = 3). These results suggest that verapamil inhibits vectorial transepithelial ion transport in a dose-dependent manner in intact monolayers.

![**Verapamil reduces short-circuit (Isc) level in H441 monolayers in a dose-dependent manner**. **(A)**Representative Isc trace showing applications of a series of concentrations. Amiloride-sensitive Isc level (AS I^basal^~sc~) is the sum of verapamil-inhibitable and residual amiloride-sensitive fractions. **(B)**Normalized AS Isc levels (AS I^vera^~sc~/AS I^basal^~sc~) at each concentration were plotted as a dose-response curve. n = 6. The raw data were fitted with the Hill equation. IC~50~value, 294.2 μM. **(C) & (D)**Verapamil on amiloride-insensitive Isc levels in amiloride pretreated cells. Representative trace **(C)**and corresponding average Isc levels before (Control) and after addition of amiloride and verapamil **(D)**. n = 3. *P*= 0.89 for the Isc levels before and after verapamil. Paired t-test.](1465-9921-11-65-2){#F2}

To measure the regulation of ENaC-associated transepithelial Isc levels by representative examples from the other three subgroups of CCB compounds, confluent H441 monolayers were exposed to nifedipine, bepridil, and diltiazem (Fig. [3](#F3){ref-type="fig"}). As shown by the representative current traces, a reduction in the Isc levels was recorded following bolus addition of nifedipine (200 μM), bepridil (10 μM), or diltiazem (50 μM) (Fig. [3A-C](#F3){ref-type="fig"}). To compare the inhibitory efficacy of these four subgroups of CCB compounds, verapamil (100 μM) was applied subsequently to these CCB compounds. Interestingly, verapamil resulted in a further decrease in the Isc levels. On average, nifedipine, bepridil, and diltiazem inhibited amiloride-sensitive (AS) Isc levels by 29.8 ± 4.4% (*P*\< 0.01, n = 4), 31.6 ± 6.6% (*P*\< 0.01, n = 3), and 11.7 ± 1.3% (*P*\< 0.01, n = 3), respectively (Fig. [3D](#F3){ref-type="fig"}). Subsequent addition of verapamil to each group showed a further reduction in the Isc levels to approximately the same level of 70% of total reduction (Fig. [3](#F3){ref-type="fig"}). Because verapamil displayed potent inhibition on the AS Isc levels in H441 cells, this drug was then used for the follow-up experiments.

![**Effects of CCB compounds on transepithelial short-circuit currents (Isc) in intact H441 monolayers**. **(A-C)**Typical traces. 200 μM nifedipine **(A)**, 10 μM bepridil **(B)**or 50 μM diltiazem **(C)**was added to the basolateral compartment followed by verapamil. Amiloride (100 μM, apical side) was finally applied to inhibit residual amiloride-sensitive currents. Arrows show the time point of addition. Total AS Isc is the difference between the Isc level before CCB and the amiloride-insensitive fraction, as indicated by a pair of vertical arrows. **(D)**CCB-sensitive fraction: CCB-inhibitable Isc/total AS Isc. One-way ANOVA. \**P*\< 0.05 *vs*Verapamil. n = 3-10.](1465-9921-11-65-3){#F3}

Verapamil, as well as other CCB compounds, is cell permeable and therefore may cross the thin alveolocapillary membrane and exhibit its inhibitory effects in the alveolar space. To investigate whether or not verapamil has the same effects on the Isc levels when applied to the basolateral and apical sides, we performed a set of experiments by adding verapamil (100 μM) to either basolateral or apical compartment (Fig. [4](#F4){ref-type="fig"}). AS Isc levels were inhibited by both basolateral and apical addition of verapamil by 41.4 ± 2.6% and 38.8 ± 1.7%, respectively (Fig. [4D](#F4){ref-type="fig"}, n = 4-17). However, addition of the same volume of water did not alter Isc level (Fig. [4A](#F4){ref-type="fig"}). These data suggest that verapamil reduces AS Na^+^channels to a similar extent regardless of its application to either luminal or interstitial compartment.

![**Comparison of verapamil-inhibitable Isc levels in H441 monolayers when applied to the apical or basolateral compartments**. **(A-C)**Representative Isc traces showing the effects of water (H~2~O), verapamil applied to basolateral **(B)**and apical **(C)**compartments. The total AS Isc levels associated with ENaC are designated by pairs of vertical arrows. **(D)**AS Isc levels before and after verapamil delivery to the basolateral side or apical compartment. Paired t-test for comparison of current levels before and after verapamil. \**P*\< 0.05 and \*\**P*\< 0.01. n = 4-17.](1465-9921-11-65-4){#F4}

Verapamil inhibits both apical and basolateral Na^+^conductance in permeabilized H441 monolayers
------------------------------------------------------------------------------------------------

It has been reported that the total Na^+^Isc level in polarized lung epithelial monolayers is predominately determined by apical and basolateral vectorial Na^+^movement \[[@B13]\]. We asked whether verapamil might regulate electrogenic pathways across both apical and basolateral membrane. To examine the effects of verapamil on apical Na^+^influx, amphotericin B (100 μM) was applied to permeabilize the basolateral membrane (Fig. [5A](#F5){ref-type="fig"}). A large Na^+^ion gradient was applied to the permeabilized H441 monolayer to facilitate passive Na^+^transport predominately through ENaC channels. To confidentially eliminate all of Na^+^/K^+^-ATPase enzymatic activity, ouabain (1 mM) was added to the basolateral compartment. Permeabilization of the basolateral membrane caused a reduction in the Isc level, suggesting that a relatively larger Na^+^gradient across apical membrane exists in intact cells (apical 145:\~10 mM in cytosol) than basolateral permeabilized monoalyers (145:25 mM). Verapamil inhibited transapical AS Isc levels from 9.5 ± 0.9 to 6.7 ± 0.8 μA/cm^2^(paired t-test, *P*\< 0.001, n = 8, Fig. [5B](#F5){ref-type="fig"}). Clearly, verapamil regulates AS apical Na^+^conductance in the absence of cytosolic soluble signal elements.

![**Inhibition of transapical and transbasolateral Isc levels by verapamil in permeabilized H441 monolayers**. **(A)**Representative Isc traces obtained in basolateral permeabilized H441 monolayers with amphotericin B (am B). 1 mM ouabain was added to the basolateral side to exclude any potential residual Isc across basolateral membrane. Amiloride (100 μM) was applied at the end of recording to calculate basal amiloride-sensitive (AS) Isc level as indicated between dashed lines. **(B)**AS Isc levels before (Basal) and after water (H~2~O) and verapamil (Verapamil). Paired t-test. \*\**\*P*\< 0.001. n = 4-8. **(C)**Representative Isc trace recorded in apically permeabilized H441 monolayers with amphotericin B. 100 μM amiloride was added to the apical compartment to inhibit possible residual Isc level carried by ENaC. Ouabain (1 mM) was added at the end of the recording to calculate total ouabain-sensitive (OS) Isc level. **(D)**Mean OS Isc levels in the absence (Basal) and presence of water (H~2~O) and verapamil (Verapamil). Paired t-test. \**P*\< 0.05. n = 4.](1465-9921-11-65-5){#F5}

We then examined the effects of verapamil on Na^+^/K^+^-ATPase in apically permeabilized confluent H441 monolayers with amphotericin B (10 μM). To eliminate possibility of any AS apical Na^+^channels still remaining in the apically permeabilized cells, amiloride (100 μM) was added to the apical compartment. As shown in Fig. [5C](#F5){ref-type="fig"}, in the presence of amiloride, apical permeabilization caused a dramatic increase in the Isc level, a hallmark of evoked Na^+^/K^+^-ATPase activity following an increment in \"cytosolic\" Na^+^ions. Verapamil resulted in a marked drop of the ouabain-sensitive (OS) Isc level from 6.0 ± 1.3 to 3.7 ± 1.1 μA/cm^2^(*P*\< 0.05, n = 4, Fig. [5D](#F5){ref-type="fig"}). These experiments provide direct evidence that verapamil inhibits Na^+^/K^+^-ATPase in the apically permeabilized H441 cells.

Verapamil serves as a K^+^channel blocker
-----------------------------------------

Verapamil has been known to alter cytosolic Ca^2+^concentration and to modify a number of K^+^channels \[[@B49]\]. We hence speculated that verapamil might indirectly influence ENaC activity by altering K^+^channels. The basolateral K^+^channels tightly regulate Na^+^/K^+^-ATPase activity, by coordinately acting as the K^+^recycling machinery to maintain the negative resting membrane potential. Resultant depolarization of polarized epithelial cells, a consequence of impaired K^+^recycling, weakens the electrochemical driving force for ENaC activity. We thereby attempted to determine the individual contribution of each functional subtype of K^+^channels (K~V~, K~Ca3.1~and K~ATP~) to verapamil-inhibited ENaC activity. The representative Isc traces showed the verapamil-induced decrease in AS Isc subsequent to addition of 100 μM clofilium, 5 μM tram34, and 100 μM glibenclamide, respectively (Fig. [6A](#F6){ref-type="fig"}). These concentrations were supposed to completely block corresponding K^+^channels as described previously \[[@B21],[@B25]\]. As summarized in Fig. [6B](#F6){ref-type="fig"}, clofilium, tram34, and glibenclamide decreased the AS Isc levels by 54.4 ± 4.6% (*P*\< 0.05, n = 4), 19.1 ± 1.8% (*P*\< 0.001, n = 7), 20.5 ± 1.1% (*P*\< 0.01, n = 4), respectively. Subsequent addition of verapamil resulted in a further reduction of the residual AS Isc levels by 23.7 ± 4.3%, 40.3 ± 1.6%, and 36.0 ± 2.8%, respectively. Blockade of KCNQ (3 and 5) \[[@B23]\] but not K~Ca3.1~and K~ATP~channels significantly affected the response of AS Na^+^channels to verapamil (Fig. [6C](#F6){ref-type="fig"}, *P*\< 0.05), when compared to the control (38.8 ± 1.7%, n = 17). Our results showed that these three subtypes of K^+^channels are functionally expressed in H441 cells at a various levels, in accordance with other studies \[[@B21],[@B25]\]. Moreover, inhibition of these K^+^channels by the related specific blockers can influence the inhibitory effects of verapamil on AS Na^+^channels to various extents.

![**K^+^channel blockers alter the inhibitory effects of verapamil in H441 cells**. **(A)**Typical Isc traces showing the application of 100 μM verapamil alone (control), 100 μM clofilium (K~V~inhibitor), 20 μM tram34 (K~Ca3.1~inhibitor), and 100 μM glibenclamide (K~ATP~inhibitor), respectively. These K^+^channel blockers were applied to basolateral side followed by verapamil and amiloride (apical side) to compute total AS Isc. **(B)**Summary of average AS Isc levels. Paired t-test. \**P*\< 0.05, \*\**P*\< 0.01, \*\*\* *P*\< 0.001 for comparison of pre- and post exposure of CCB. n = 4-17. **(C)**Reduced percentages of AS Isc levels by verapamil in H441 cells with and without pretreatment of K^+^channel blockers. Two-sample, two-tailed t-test. \**P*\< 0.05 *vs*Control. n = 4-17.](1465-9921-11-65-6){#F6}

K^+^channel openers restore verapamil-inhibited Isc levels in intact H441 cells
-------------------------------------------------------------------------------

Our *in vivo*studies suggest K^+^channel openers may alter ENaC-like activity. To address this issue, K^+^channel openers were added basolaterally subsequent to verapamil (100 μM) as shown in Fig. [7A](#F7){ref-type="fig"}. A set of increasing concentrations for pyrithione-Na (K~V7.1~opener at 5 μM and KCNQ at larger concentrations), 1-EBIO (K ~Ca3.1~opener), and minoxidil (K~ATP~opener) were applied to the basolateral compartment. The average concentration-response curves were plotted in Fig. [7B](#F7){ref-type="fig"}. The half-maximal effective concentrations (EC~50~) were 2.4 μM, 391.8 μM, and 1.2 μM, respectively, for pyrithione-Na, 1-EBIO, and minoxidil. To maximally activate these K^+^channels, the concentration used for each type of K^+^channels was based on the results of the dose-response studies (Fig. [7A](#F7){ref-type="fig"} &[7B](#F7){ref-type="fig"}). As shown in Fig. [7C](#F7){ref-type="fig"}, pyrithione-Na (10 μM), 1-EBIO (600 μM), and minoxidil (10 μM) significantly increased AS Isc levels from 14.9 ± 1.7 to 17.8 ± 2.4 μA/cm^2^(*P*\< 0.01, n = 6), 12.9 ± 1.9 to 18.6 ± 2.6 μA/cm^2^(*P*\< 0.01, n = 6), and 14.9 ± 2.4 to 19.4 ± 2.8 μA/cm^2^(*P*\< 0.05, n = 3), respectively. These encouraging observations imply that stimulating K^+^secretion with K^+^channel openers can reverse, at least partially, verapamil-inhibited AS transepithelial Na^+^pathways. In fact, this set of experiments was initiated with a low dose of pyrithione-Zn (ZnPy, 10 μM), which was supposed to specifically open heterologously expressed K~V~LQT1 current, one of large K~V~family \[[@B50]\]. Interestingly, only a transient increment was observed followed by a continuing decline in an hour (Additional file [1](#S1){ref-type="supplementary-material"}). This is likely due to the non-specific effects of Zn^2+^ions on transepithelial ion transport systems, including ENaC \[[@B51]-[@B54]\]. We thus had to utilize its sodium compound, which has a divergent EC~50~value for native K~V~channels in H441 cells (Fig. [7B](#F7){ref-type="fig"}).

![**Stimulatory effects of K^+^channel openers subsequent to verapamil in H441 monolayers**. **(A)**Representative traces showing response to a set of K^+^channel openers from 1 μM to 1 mM in the presence of verapamil. **(B)**Corresponding concentration-response curves. The raw data were fitted with the Hill equation and the EC~50~were 2.4, 391.8, and 1.2 μM, respectively, for pyrithione-Na, 1-EBIO, and minoxidil. **(C)**Summary of AS Isc levels before (Basal) and after verapamil (Verapamil) and K^+^channel openers (10 μM Pyrithione-Na, 600 μM 1-EBIO, 10 μM Minoxidil). Paired t-test. \**P*\< 0.05, \*\**P*\< 0.01 for comparison of before and after K^+^channel openers. n = 3-6.](1465-9921-11-65-7){#F7}

We also tried to prevent the inhibitory effects of verapamil on the AS Isc levels by addition of K^+^channel openers prior to verapamil. The similar transient or sustained elevation in the Isc levels was observed following the application of the K^+^channel openers but inexplicably the subsequent application of verapamil inhibited Isc levels to the same extent as that of control monolayers in the absence of K^+^channel openers (data not shown). In sharp contrast to the significant recovery effects of verapamil-inhibited ion transport, the K^+^channel openers did not prevent the verapamil-induced depression in transepithelial ion transport. These observations indicate that instead of keeping K^+^channels from the inhibitory of verapamil, K^+^channel openers are only able to recover impaired K^+^channel activities.

Diverse stimulating effects of K^+^channel openers on apical and basolateral ion transport
------------------------------------------------------------------------------------------

Recovery of verapamil-inhibited transepithelial Isc levels in H441 cells (Fig. [7](#F7){ref-type="fig"}) by the K^+^channel openers raised a new question of what Na^+^transport systems are regulated by the K^+^channel openers, apical ENaC or basolateral Na^+^/K^+^-ATPase. To address this question, K^+^channel openers were applied to either apical or basolateral membrane permeabilized monolayers. In basolateral permeabilized cells, neither KCNQ (pyrithione-Na) nor K~ATP~(minoxidil) channel openers altered AS transapical Na^+^influx (Fig. [8A](#F8){ref-type="fig"} &[8C](#F8){ref-type="fig"}). However, K~Ca3.1~channel opener (1-EBIO) approximately restored half (49.1 ± 22.3%) of the depressed AS Isc level. Regarding transbasolateral ion transport, pyrithione-Na and 1-EBIO but not minoxidil (64.6 ± 9.2%) completely restored the verapamil-inhibited OS Isc levels in apical membrane permeabilized H441 monolayers (Fig. [8B](#F8){ref-type="fig"} &[8D](#F8){ref-type="fig"}). Taken together, these results suggest that K~Ca3.1~channels are probably located at both apical and basolateral membranes in H441 cells, while pyrithione- and minoxidil-activated channels may be expressed at the basolateral membrane only.

![**Compartment-dependent recovery of verapamil-inhibited Isc levels by K^+^channel openers in permeabilized H441 monolayers**. **(A)**Representative Isc traces of apical Isc level in the presence of 1 mM ouabain in the basolateral membrane permeabilized monolayers. **(B)**Representative Isc traces of basolateral Isc level in the presence of 100 mM amiloride in the apical permeabilized H441 monolayers. **(C & D)**Recovered apical **(C)**and basolateral **(D)**Isc levels by K^+^channel openers. One-way ANOVA for comparing normalized Isc level post K^+^channel openers with total AS or OS Isc levels. \**P*\< 0.05 and \*\**P*\< 0.01. n = 3-5.](1465-9921-11-65-8){#F8}

Direct regulation of αβγ ENaC by verapamil in *X. laevis*oocytes
----------------------------------------------------------------

To address the question of whether verapamil directly regulate human ENaC, human α, β, and γ ENaC subunits were co-expressed in *X. laevis*oocytes, and the effects of verapamil on heterologously expressed ENaC were assessed. Verapamil inhibited ENaC current in an oocyte under physiological conditions (Fig. [9A](#F9){ref-type="fig"}), which is consistent with the results in H441 cells. An average of 38.2 ± 5.5% ENaC currents was reduced by verapamil (*P*\< 0.05, n = 4, Fig. [9C](#F9){ref-type="fig"}), suggesting that verapamil may also directly reduce native ENaC channel activity in H441 cells.

![**Verapamil regulates heterologously expressed human αβγ ENaC in oocytes in a Ca^2+^-dependent pattern**. **(A & B)**Time-courses of whole-cell current traces at -100 mV recorded in oocytes perfused with verapamil under normal **(A)**and Ca^2+^-chelated conditions **(B)**. 10 μM amiloride were added at the end of recording to compute basal and verapamil-inhibitable ASI levels. **(C & D)**Effects of verapamil on ENaC activity in control **(C)**and Ca^2+^-chelated **(D)**oocytes. The shift of base line in Ca^2+^-chelated cells **(B)**was corrected for comparing the current levels before (Basal) and after verapamil (Verapamil). Paired t-test. \**P*\< 0.05.](1465-9921-11-65-9){#F9}

If intracellular Ca^2+^signal mediates the down-regulation of αβγ ENaC by verapamil, one may expects that cell permeable Ca^2+^chelator could have the same effect. To address this issue, BAPTA_AM was superfused on oocytes bathed in the Ca^2+^-free solution. In an oocyte perfused with the Ca^2+^-free bath solution (5 mM EGTA, 0 mM Ca^2+^), the whole-cell ENaC current declined gradually (Fig. [9B](#F9){ref-type="fig"}). The residual ENaC currents were no longer sensitive to verapamil under these Ca^2+^-depletion conditions (the ENaC current even increased by 0.4 ± 1.5% after correction of the run-down slope, *P*\>0.05 compared with basal current, n = 4, Fig. [9D](#F9){ref-type="fig"}). Obviously, verapamil down-regulates human αβγ ENaC in a cytosolic Ca^2+^- dependent fashion in oocytes. We also tried to repeat these experiments in Ca^2+^depleted H441 monolayers, unfortunately, the resistance and current levels post BAPTA_AM exposure were too low to detect due to impaired gap junctions and ion transport (data not shown).

Verapamil alters cytosolic Ca^2+^signal
---------------------------------------

The regulation of alveolar ENaC by Ca^2+^signal has been documented by the well-designed *in vivo*and *in vitro*studies \[[@B55],[@B56]\]. We reason that verapamil may interfere with transepithelial Na^+^transport by altering cell Ca^2+^signal, which is regulated by mechanic stress associated with breath. The intracellular Ca^2+^signal was measured with Fluo 4AM in real time using confocal microscopy (Additional files [1](#S1){ref-type="supplementary-material"} &[2](#S2){ref-type="supplementary-material"}) in H441 cells in the absence or presence of verapamil. Ionomycin was added to the chamber to mimic the Ca^2+^wave caused by breath. An approximately three-fold increment in fluorescent intensity was observed following the exposure to ionomycin (Fig. [10A](#F10){ref-type="fig"} &[10B](#F10){ref-type="fig"}, Additional file [2](#S2){ref-type="supplementary-material"}). In comparison, this increment was significantly diminished in the presence of verapamil (Fig. [10A](#F10){ref-type="fig"} &[10B](#F10){ref-type="fig"}, Additional file [3](#S3){ref-type="supplementary-material"}). In addition, the time required to reach the maximal value of fluorescent intensity was considerably prolonged in verapamil exposed cells (Fig. [10C](#F10){ref-type="fig"}, *P*\< 0.05).

![**Verapamil inhibits ionophore-induced Ca^2+^mobilization**. Transient Ca^2+^signal evoked by ionomycin was measured as relative fluorescent intensity with Fluo 4AM dye in real time with paired manner, in both control and verapamil incubated H441 cells. **(A)**Original traces showing on-time Ca^2+^signal digitized in control (red) and verapamil exposed cells (green). **(B)**Maximal relative change in fluorescent intensity (F~peak~/F~0~). Nonparametric Mann-Whitney U-test. \**P*\< 0.05 vs Control. n = 3. **(C)**The time to reach peak signal. Nonparametric Mann-Whitney U-test. \**P*\< 0.05](1465-9921-11-65-10){#F10}

Discussion
==========

We aimed to study the cellular mechanistic pathogenesis of the CCB-induced noncardiogenic defect in lung fluid clearance. Ussing chamber studies suggest that transepithelial Na^+^transport is inhibited by four structurally distinct subgroups of CCB compounds in human lung epithelial cells (H441 cells). Verapamil reduces amiloride-sensitive (AS) Isc levels in a concentration-dependent manner. Ca^2+^signal is involved in the down-regulation of AS Na^+^transport by verapamil. Furthermore, verapamil alters K^+^recycling via stimulating the apical and basolateral K^+^channels as well as Na^+^/K^+^-ATPase activity. K^+^channel openers restore the suppressed ENaC activity *in vitro*to a significant extent. Of note, our *in vivo*alveolar fluid clearance (AFC) studies show that K^+^channel openers restore the verapamil-inhibited fluid resolution.

A Ca^2+^signal has been shown to up-regulate alveolar fluid clearance and epithelial Na^+^channel activity \[[@B55],[@B57]\]. Depletion of intracellular Ca^2+^by thapsigargin in late-gestational guinea pig lungs completely inhibited amiloride-sensitive AFC \[[@B55]\]. On the other hand, elevation of intraepithelial Ca^2+^concentration by β-adrenergic agonists and other AFC-enhancing reagents, for example, terbutaline, has been confirmed \[[@B58]\]. CCB partially blocked terbutaline-stimulated Na^+^absorption via amiloride-sensitive channels in primary rat alveolar type II cells \[[@B57],[@B59]\]. Our results that show BAPTA_AM completely abolishes verapamil-induced inhibition of αβγ ENaC activity in oocytes suggest that the regulation of ENaC by CCB is at least partially mediated by an alteration in cytosolic Ca^2+^signal (Fig. [10](#F10){ref-type="fig"}). The observation that verapamil inhibits ionophore-induced Ca^2+^mobilization supports this notion. The direct inhibitory effects of Ca^2+^ions on ENaC *in vitro*\[[@B60],[@B61]\] were, perhaps, overwhelmed by the stimulatory effects of Ca^2+^downstream signals on ENaC and other transporters in these cell models and *in vivo*studies.

Accumulating evidence demonstrates that the regulation of epithelial K^+^channels by the Ca^2+^signal. The expression of various K^+^channels has been detected in alveolar and bronchial epithelial cells \[[@B20]\]. Ca^2+^signal may regulate those K^+^channels by both directly affecting the gating kinetics and serving as a second messenger for signal transduction. On the other hand, the relationship between a Ca^2+^signal and Na^+^/K^+^-ATPase is not known. Control of endoplasmic reticulum (ER) Ca^2+^release by Na^+^/K^+^-ATPase has been recently confirmed in \"knockout\" cultured renal epithelial cells \[[@B62]\]. It raises the possibility that CCB may directly inhibit Na^+^/K^+^-ATPase and in turn alter the intracellular Ca^2+^content. Nevertheless, our data clearly confirm that impaired K^+^ion transport across alveolar basolateral membrane is an essential mechanism for CCB to inhibit ENaC function. Interruption of K^+^ion recycling may be a critical mechanism for CCB-induced inhibition of ENaC activity (Fig. [11](#F11){ref-type="fig"}).

![**Schematic model for the multiple mechanisms of CCB-inhibited transepithelial Na^+^transport and recovery by K^+^channels**. CCB compounds alter Ca^2+^signal most likely via modifying Ca^2+^release from cytosolic compartments. In addition, CCB compounds directly regulate K^+^channels, ENaC, and Na^+^/K^+^-ATPase. Disrupted basolateral K^+^recycling and apical ion transport will abrogate transalveolar salt and fluid transport. K^+^channel openers significantly restore the CCB-inhibited transepithelial Na^+^transport by activating K^+^channel, then facilitating Na^+^/K^+^-ATPase.](1465-9921-11-65-11){#F11}

What are the underlying mechanisms for the diverse regulation of apical and basolateral conductance by K^+^channel openers? If the K^+^channel openers restore the depressed ENaC and Na^+^/K^+^-ATPase by stimulating K^+^influx which facilitates Na^+^/K^+^-ATPase in intact cells, no effects on ENaC should be observed in basolateral permeabilized monolayers. Intriguingly, K ~Ca3.1~channel opener still activated ENaC. It is possible that K~Ca~channels are expressed in apical membrane \[[@B29]\]. Increased extrusion of K^+^ions in the presence of 1-EBIO may locally build up an electrical gradient resulting in elevated ENaC activity. Another possibility is that 1-EBIO directly stimulates ENaC. The less effect of minoxidil in permeabilized monolayers, by comparison to the results in intact H441 cells, *in vivo*fluid clearance, and previous publication \[[@B29]\], may be due to loss of cell ATP.

CCB compounds may not act on the same Ca^2+^entry/exit pathways due to their divergent pharmaceutical properties \[[@B63]\]. Lung epithelial Ca^2+^content is determined by Ca^2+^influx/efflux pathways, endoplasmic reticulum (ER) Ca^2+^release, and concentration of Ca^2+^-binding proteins. Ca^2+^ions may enter epithelia through, for example, L-type Ca^2+^channels, ECaC, and other TRP channels; while Ca^2+^-ATPase and Ca^2+^/Na^+^exchanger are major transporters to extrude Ca^2+^ions. Our results indicate that verapamil may not alter basal Ca^2+^content, instead, the Ca^2+^wave, possibly due to Ca^2+^release from cytosolic compartments, was abolished (Fig. [11](#F11){ref-type="fig"}).

The potent efficacy of K^+^channel openers to recover transepithelial Na^+^reabsorption and fluid clearance may be a promising therapeutic approach to mitigate drug-induced as well as other deleterious agents-induced noncardiogenic lung edema. On the other hand, inhalation CCB compounds will definitely bring life-threatening noncardiogenic lung edema to patients. Reasonably, any medicines capable of depleting lung epithelial Ca^2+^ions may have the same fatal side-effect when delivered either intravenously or intratracheally. Indeed, nifedipine cannot prevent lung edema in mountain sickness \[[@B64]\].

As supported by our observations in permeabilized H441 monolayers and Ca^2+^-depleted cells, verapamil inhibited basolateral and apical K^+^conductance directly. Verapamil inhibits IK (K~Ca3.1~) channels with an IC~50~value of 72 μM, various K~V~channel subtypes between 10-200 μM and K~ATP~channels at \~10 μM \[[@B65]-[@B67]\]. Moreover, concentrations typically used to achieve nearly complete inhibition of voltage-gated Ca^2+^channels is less than 100 μM. Therefore, it is most likely that verapamil alters ENaC activity via multiple mechanisms, for example, through Ca^2+^-mediated regulation, direct inhibition of ENaC, and interrupting K^+^recycling (Fig. [11](#F11){ref-type="fig"}). In summary, CCB reagents decrease vectorial transepithelial Na^+^transport directly by inhibiting apical ENaC and indirectly by altering cytosolic Ca^2+^signal and K^+^recycling at the basolateral membrane. Recovery of the CCB-depressed edema resolution by K^+^channel openers indicates that pharmaceutical augmentation of K^+^recycling may be a potent strategy to combat CCB-induced noncardiogenic lung edema.
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###### Additional file 1

**Pyrithione zinc on K~V~in H441 cells**. The specific blocker for heterologously expressed K~V~channels, pyrithione zinc transiently actives AS Isc followed by a pronounced decline. The remaining Isc level is approximately 0 for AS Isc fraction.
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###### Additional file 2

**Video clip in a control H441 cell**. Fluo 4AM fluorescent intensity was monitored in real time before and after addition of ionomycin.

###### 

Click here for file

###### Additional file 3

**Video clip in a verapamil incubated H441 cell**. Fluo 4AM fluorescent intensity was monitored in real time before and after addition of ionomycin.
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